← SynDRA
CLOCORTOLONE PIVALATE
SynDRA canonical compound SYN0023318 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | NR3C1 |
|---|
| Mechanism of action | Steroid |
|---|
| Indication | corticosteroid-responsive dermatoses |
|---|
| Disease area | dermatology |
|---|
All known targets
Mechanisms of action (all sources)
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- AR
- PGR
- ADORA3
- ACHE
- IDH1
- SLC6A4
- SLC6A3
- SLC6A2
- SAMHD1
- PTGS1
- PDE4A
- PDE3A
- OPRM1
- NFE2L2
- MAOA
- HTR1A
- HTR2B
- HRH3
- HDAC6
- F2
- ESR1
- DRD3
- DRD1
- CHRM2
- CHRM1
- ATAD5
- ADRA2A
- ADRA1A
- TBXA2R
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Drug classes
- Corticosteroid Hormone Receptor Agonists
- Corticosteroid
- Anti-Inflammatory Agents
- Glucocorticoids
- Hormones
- Steroid
ATC classes
Cross-references
Synonyms
- CLODERM
- Cloderm
- clocortolone trimethylacetate
- Clocortolone 21-pivalate
- SH-863
- clocortolone-pivalate
- clocortolone.pivalate
- QBL8IZH14X
- Purantix
- CLOCORTOLONE PIVALATE (200 MG)
- MLS002154165
- CHEBI:59583
- Cilder
- CL 68
- UNII-QBL8IZH14X
- Clocortolone pivalate [USAN]
- Clocortolone pivalate [USAN:USP]
- NCGC00016824-01
- Cloderm (TN)
- EINECS 251-826-5
- CAS-34097-16-0
- Prestwick0_001119
- Prestwick1_001119
- Prestwick2_001119
- Prestwick3_001119
- SCHEMBL5120
- Clocortolone pivalate (USP)
- BSPBio_001258
- SPBio_003119
- BPBio1_001383
- CHEMBL1200975
- DTXSID0045460
- HMS1571O20
- HMS2098O20
- HMS2236M06
- HMS3715O20
- ZINC4212603
Look up CLOCORTOLONE PIVALATE in the interactive SynDRA portal →